Mechanistic insights into the antiviral effects of curcumin and piperine against Hepatitis C virus: a study of their bioactive properties in hepatocarcinoma cells

World Health Orgnization. Global hepatitis report, 2021. [http://www.who.who.int/news-room/hepatitits-c,July27,2021/publications/global-hepatitis/en/]. [Accessed: 14 oct 2021]. World Health Orgnization. Hepatitis C (fact sheet). [https://www.who.int/news-room/fact-sheets/detail/hepatitis-c]. [Accessed: 09 Mar 2022]. Centers for disease control and prevention. Hepatitis C FAQs for health professionals. [https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm#section1]. [Accessed: 6 Jun 2021]. Gonzalez FA, Van den Eynde E, Perez-Hoyos S, Navarro J, Curran A, Burgos J, et al. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients. HIV Med. 2015; 16: 211-218. [http://dx.doi.org/10.1111/hiv.12197]. Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, Walewska-Zielecka B, Marczyńska M. The influence of hepatitis B and C virus coinfection on liver histopathology in children. Eur J Pediatr. 2015; 174: 345-353. [http://dx.doi.org/10.1007/s00431-014-2402-7]. Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, et al. Hepatitis C virus infection. Nat Rev Dis Primers. 2017; 3: 17006. [http://dx.doi.org/10.1038/nrdp.2017.6]. Biesalski HK, Gragsted LO, Elmadfa I, Grossklaus R, Müller M, Schrenk D, et al. Bioactive compounds: Definition and assessment of activity. Nutrition. 2009; 25: 1202-1205. [http://dx.doi.org/10.1016/j.nut.2009.04.023]. Calland N, Dubuisson J, Rouillé Y, Séron K. Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 2012; 4: 2197–2217. [http://dx.doi.org/10.3390/v4102197]. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005; 1056: 206-217. [http://dx.doi.org/10.1196/annals.1352.010]. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41: 40-59. [http://dx.doi.org/10.1016/j.biocel.2008.06.010]. Rechtman MM, Har-Noy O, Bar-Yishay I, Fishman S, Adamovich Y, Shaul Y, et al. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α. FEBS Lett. 2010; 584: 2485-2490. [http://dx.doi.org/10.1016/j.febslet.2010.04.067]. Anggakusuma, Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 2014; 63: 1137-1149. [http://dx.doi.org/10.1136/gutjnl-2012-304299] . Kumar D, Basu S, Parija L, Rout D, Manna S, Dandapat J, et al. Curcumin and ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells. Biomed. Pharmacother. 2016; 81: 31-37. [http://dx.doi.org/10.1016/j.biopha.2016.03.037]. Musso G, Cassader M, Gambino R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov. 2016; 15: 249-274. [http://dx.doi.org/10.1038/nrd.2015.3]. Chen LC, Chen YC, Su CY, Wong WP, Sheu MT, Ho HO. Development and characterization of lecithin-based self-assembling mixed polymeric micellar (saMPMs) drug delivery systems for curcumin. Sci Rep. 2016; 6: 37122. [http://dx.doi.org/10.1038/srep37122]. Tawani A, Amanullah A, Mishra A, Kumar A. Evidences for piperine inhibiting cancer by targeting human G-quadruplex DNA sequences. Sci Rep. 2016; 6: 39239. [http://dx.doi.org/10.1038/srep39239]. Lai LH, Fu QH, Liu Y, Jiang K, Guo QM, Chen QY, et al. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin. 2012; 33: 523–530. [http://dx.doi.org/10.1038/aps.2011.209]. Randino R, Grimaldi M, Persico M, De Santis A, Cini E, Cabri W, et al. Investigating the neuroprotective effects of turmeric extract: structural interactions of β-amyloid peptide with single curcuminoids. Sci Rep. 2016; 6: 38846. [http://dx.doi.org/10.1038/srep38846]. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Pl Med. 1998; 64: 353-356. [http://dx.doi.org/10.1055/s-2006-957450]. Zhou J, Donatelli SS, Gilvary DL, Tejera MM, Eksioglu EA, Chen X, et al. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin. Sci Rep. 2016; 6: 29521. [http://dx.doi.org/10.1038/srep29521]. Rieger AM, Nelson KL, Konowalchuk JD, Barreda DR. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp. 2011; 24(50): 2597. [https://doi.org/10.3791/2597]. Xiang J, Wan C, Guo R, Guo D. Is hydrogen peroxide a suitable apoptosis inducer for all cell types? BioMed Res Int. 2016; 2016: 7343965. [http://dx.doi.org/10.1155/2016/7343965]. ISO 10993-5 (2005) Biological Evaluation of Medical Devices – Part 5: Tests for in vitro cytotoxicity. Geneva, Switzerland: International Standards Organization, Geneva, Switzerland. Li M, Gao M, Fu Y, Chen C, Meng X, Fan A, Kong D, et al. Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery. Colloids Surf B Biointerfaces. 2016; 140: 11-18. [http://dx.doi.org/10.1016/j.colsurfb.2015]. Jiang J, Jin H, Liu L, Pi J, Yang F, Cai J. Curcumin disturbed cell-cycle distribution of HepG2 cells via cytoskeletal arrangement. Scanning. 2013; 35: 253-260. [http://dx.doi.org/10.1002/sca.21058]. Prasad NS, Raghavendra R, Lokesh BR, Naidu KA. Spice phenolics inhibit human PMNL-5 lipoxygenase. Prostaglandins Leukot Essent Fatty Acids. 2004; 70: 521-528. [http://dx.doi.org/10.1016/j.plefa.2003.11.006]. Raghavendra RH, Naidu KA. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostaglandins Leukot Essent Fatty Acids. 2009; 81: 73-78. [http://dx.doi.org/0.1016/j.plefa.2009.04.009]. Derosa G, Maffioli P, Simental-Mendía LE, Bo S, Sahebkar A. Effect of curcumin on circulating interleukin-6 concentrations A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016; 111: 394-404. [http://dx.doi.org/10.1016/j.phrs.2016.07.004]. Rinwa P, Kumar A. Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Res. 2012; 1488: 38-50. [http://dx.doi.org/10.1016/j.brainres.2012.10.002]. Singh S, Kumar P. Neuroprotective Activity of Curcumin in Combination with Piperine against Quinolinic Acid Induced Neurodegeneration in Rats. Pharmacology. 2016; 97: 151-160. [http://dx.doi.org/10.1159/000443896.0]. Olmedo E, Costa J, López-Labrador FX, Forns X, Ampurdanés S, Maluenda MD, et al. Comparative study of a modified competitive RT-PCR and Amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum. J Med Virol. 1999; 58: 35-43. [http://dx.doi.org/10.1002/(sici)1096-9071(199905)58:135::aid-jmv5>3.0.co;2-v]. Elkady A, Tanaka Y, Kurbanov F, Sugauchi F, Sugiyama M, Khan A, et al. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4. J Med Virol. 2010; 82: 1878-888. [http://dx.doi.org/10.1002/jmv.21911]. Vrtačnik P, Kos Š, Bustin SA, Marc J, Ostanek B. Influence of trypsinization and alternative procedures for cell preparation before RNA extraction on RNA integrity. Anal Biochem. 2014; 463: 38-44. [http://dx.doi.org/10.1016/j.ab.2014.06.017]. Kim K, Kim KH, Kim HY, Cho HK, Sakamoto NJ. Cheong. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett. 2010; 584: 707-712. [http://dx.doi.org/10.1016/j.febslet.2009.12.019]. Chen MH, Lee MY, Chuang JJ, Li YZ, Ning ST, Chen JC, et al. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Int J Mol Med. 2012; 30: 1021-1028. [https://doi.org/10.3892/ijmm.2012.1096]. Assis RP, Arcaro CA, Gutierres VO, Oliveira JO, Costa PI, Bavieira AM, et al. Combined effects of curcumin and lycopene or bixin in yoghurt on inhibition of LDL oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats. Int J Mol Sci. 2017; 18: 332. [https://doi.org/10.3390/ijms18040332]. Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M, et al. NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations. Int J Mol Sci. 2016; 17: 803. [https://doi.org/10.3390/ijms17060803]. Prata TVG, Silva DSRD, Manchiero C, Dantas BP, Mazza CC, Nunes AKDS, et al. MTTP polymorphisms and hepatic steatosis in individuals chronically infected with hepatitis C virus. Arch Virol. 2019; 164: 2559–2563. [https://doi.org/10.1007/s00705- 019-04352-4]. Magri MC, Manchiero C, Prata TVG, Nunes AKDS, Oliveira Junior JS, Dantas BP, et al. The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis. Diagn Microbiol Infect Dis. 2020; 97(2): 115025. [https://doi.org/10.1016/j.diagmicrobio. 2020.115025]. Zampino R, Ingrosso D, Durante-Mangoni E, Capasso R, Tripodi MF, Restivo L, et al. Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. J Viral Hepat. 2008; 15: 740-746. [https://doi.org/10.1111/j.1365-2893.2008.00994.x] . Cai T, Dufour JF, Muellhaupt B, Gerlach T, Heim M, Moradpour D, et al. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. J Hepatol. 2011; 55: 529-535. [https://doi.org/10.1016/j.jhep.2010.12.020]. Liu Y, Conlon DM, Bi X, Slovik KJ, Shi J, Edelstein HI, Millar JS, et al. Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress. Cell Rep. 2017; 19: 1456-1466. [https://doi.org/10.1016/j.celrep.2017.04.064]. Winther M, Shpitzen S, Yaacov O, Landau J, Oren L, Foroozan-Rosenberg L, et al. In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in MTTP explain only part of LDL variability in an FH family. J Lipid Res. 2019; 60: 1733-1740. [https://doi.org/10.1194/jlr.M092049]. Ellis KL, Hooper AJ, Burnett JR, GF Watts. Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism. Nat Rev Endocrinol. 2016; 12: 467-484. [https://doi.org/10.1038/nrendo.2016.69]. Charlton-Menys V, Durrington PN. Human cholesterol metabolism and therapeutic molecules. Exp Physiol. 2008; 93: 27-42. [https://doi.org/10.1113/expphysiol.2007.035147]. Parhofer KG. The treatment of disorders of lipid metabolism. Dtsch Arztebl Int. 2016; 113: 262-268. [https://doi.org/10.3238/arztebl.2016.0261]. Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ. Quantitation of apoptosis and necrosis by annexin V binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc. 2016; 2016:. [https://doi.org/10.1101/pdb.prot087288]. Aggarwal BB, Deb L, Prasad S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules 2015; 20: 185-205. [https://doi.org/10.3390/molecules20010185] . J Wang, Wang C, Bu G. Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Exp Ther Med. 2018; 15: 3650-3658. [https://doi.org/10.3892/etm.2018.5805]. Shiu TY, Huang SM, Shih YL, Chu HC, Chang WK, Hsieh TY. Hepatitis C virus core protein down-regulates p21Waf1/Cip1 and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells. PLoS One. 2017; 12: e0181299. [https://doi.org/10.1371/journal.pone.0181299]. Wu LY, Chen CW, Chen LK, Chou HY, Chang CL, Juan CC. Curcumin Attenuates Adipogenesis by Inducing Preadipocyte Apoptosis and Inhibiting Adipocyte Differentia-tion. Nutrients. 2019; 11: 2307. [https://doi.org/10.3390/nu11102307]. Han SZ, Liu HX, Yang LQ, Cui LD, Xu Y. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing bcl-2 signaling pathway via inactivating STAT3/NF-κB. Biomed Pharmacother. 2017; 96: 1403-1410. [https://doi.org/10.1016/j.biopha.2017.11.022]. Lin Y, Xu J, Liao H, Li L, Pan L. Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway. Tumour Biol 35(2014) 3305-10. [https://doi.org/10.1007/s13277-013-1433-4]. Gunasekaran V, Elangovan K, Niranjali Devaraj S. Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. Food Chem Toxicol. 2017; 105: 106-118. [https://doi.org/10.1016/j.fct.2017.03.029]. Tikhanovich I, Kuravi S, Campbell RV, Kharbanda KK, Artigues A, Villar MT, et al. Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure. Hepatology. 2014; 59(1): 58-70. [https://doi.org/10.1002/hep.26618]. Tikhanovich I, Cox J, Weinman SA. Forkhead box class O transcription factors in liver function and disease. J Gastroenterol Hepatol. 2013; 28: 125-131. [https://doi.org/10.1111/jgh.12021]. Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018; 19: 121-135. [https://doi.org/10.1038/nrm.2017.95]. Mankouri J, Tedbury PR, Gretton S, Hughes ME, Griffin SD, Dallas ML, et al. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. Proc Natl Acad Sci U S A. 2010; 107(25): 11549–11554. [https://doi.org/10.1073/pnas.0912426107]. Liu Z, Cui C, Xu P, Dang R, Cai H, Liao D, et al. Curcumin activates AMPK pathway and regulates lipid metabolism in rats following prolonged clozapine exposure. Front Neurosci. 2017; 11: 558. [https://doi.org/10.3389/fnins.2017.00558]. Seren S, M Mutchnick, Hutchinson D, Harmanci O, Bayraktar Y, Mutchnick S, et al. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Nutr Cancer. 2008; 60(6): 729-735. Disponível em: [https://doi.org/10.1080/01635580802419772] . Dolka I, Król M, Sapierzyński R. Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: an immunohistochemical and prognostic study. Res Vet Sci. 2016; 105: 124-133. [http://dx.doi.org/10.1016/j.rvsc.2016.02.004]. Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, V Tzelepi, et al. Increased bax/bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with Myasthenia gravis. In Vivo. 2007; 21(1): 123-132. [https://pubmed.ncbi.nlm.nih.gov/17354625/]. Masalova OV, Lesnova EI, Solyev PN, Zakirova NF, Prassolov VS, Kochetkov SN, et al. Modulation of cell death pathways by hepatitis C virus proteins in Huh7.5 hepatoma cells. Int J Mol Sci. 2017; 18(11): 2346. [https://doi.org/10.3390/ijms18112346]. Pal MK, Jaiswar SP, Srivastav AK, Goyal S, Dwivedi A, Verma A, et al. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, bax/bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells. Eur J Pharmacol. 2016; 791: 751–762. [http://dx.doi.org/10.1016/j.ejphar.2016.10.019]. Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017; 169: 381-405. [https://doi.org/10.1016/j.cell.2017.04.001]. Liu Z, Tian Y, Machida K, Lai MM, Luo G, Foung SK, Ou JH. Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry. J Biol Chem. 2012; 287: 41922-41930. [https://doi.org/10.1074/jbc.M112.414789]. Shi Q, Hoffman B, Liu Q. PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs. Virology. 2016; 490: 99-108. [https://doi.org/10.1016/j.virol.2016.01.012] . Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017; 16: 79. [https://doi.org/10.1186/s12943-017-0648-1].